What is the recommended daily ileostomy output?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ileostomy Output Management

The goal is to maintain ileostomy output below 1200 ml/day, with outputs exceeding this threshold requiring active intervention to prevent dehydration, electrolyte disturbances, and renal complications. 1

Defining Normal vs. High Output

  • Normal ileostomy output ranges from 500-800 ml/day in well-adapted patients 2
  • High-output ileostomy is defined as >1200 ml/day, requiring medical management 1, 3
  • Outputs of 1200-2000 ml/day typically require oral fluid restriction and glucose-saline solutions 1
  • Outputs >2000 ml/day indicate severe high-output stoma requiring aggressive intervention including potential parenteral support 4

Treatment Goals and Monitoring

The primary aims are maintaining hydration/body weight and achieving a daily urine volume of at least 800 ml with sodium concentration >20 mmol/L. 1

Key Monitoring Parameters:

  • Daily stoma output volume and consistency 1
  • Urine volume and sodium concentration 1
  • Body weight and hydration status 1
  • Serum electrolytes, particularly magnesium and potassium 1

Stepwise Management Algorithm

Step 1: Exclude Reversible Causes

Before implementing output reduction strategies, rule out:

  • Intra-abdominal sepsis or partial bowel obstruction 1, 5
  • Enteritis (Clostridium difficile, Salmonella) 1, 3
  • Recurrent underlying disease (Crohn's disease, radiation enteritis) 1
  • Medication-related causes (sudden steroid/opiate withdrawal, prokinetics) 1

Step 2: Fluid Management (First-Line)

Restrict hypotonic oral fluids to <500 ml/day (water, tea, coffee, fruit juices, alcohol) as these paradoxically increase stomal sodium losses. 1, 5

Replace fluid requirements with glucose-saline solution containing ≥90 mmol/L sodium, sipped throughout the day. 1

Recommended Oral Rehydration Solutions:

  • Modified WHO cholera solution: 60 mmol sodium chloride (3.5 g) + 30 mmol sodium bicarbonate (2.5 g) + 110 mmol glucose (20 g) per liter 1
  • Alternative solution: 120 mmol sodium chloride (7 g) + 44 mmol glucose (8 g) per liter 1

For outputs 1200-2000 ml/day, patients can often maintain sodium balance with glucose-saline solutions or salt capsules (500 mg, up to 14 capsules/24 hours). 1

Step 3: Antimotility Medications (Second-Line)

Loperamide is the preferred first-line antimotility agent, given 30 minutes before meals. 1, 5, 6

  • Standard dosing: 4 mg four times daily 1
  • High-dose regimen: 12-24 mg per dose may be needed due to disrupted enterohepatic circulation 1
  • Expected effect: 20-30% reduction in water and sodium output 1
  • Loperamide is superior to codeine phosphate as it is non-sedating, non-addictive, and doesn't cause fat malabsorption 1

Codeine phosphate 60 mg four times daily can be added if loperamide alone is insufficient. 1, 5

Step 4: Antisecretory Medications (Third-Line)

For outputs >2 liters/day or net secretory states, add gastric acid suppression:

  • Omeprazole 40 mg orally once daily (or 40 mg IV twice daily if <50 cm jejunum remains) 1
  • Ranitidine 300 mg orally twice daily 1
  • Cimetidine 400 mg orally or IV four times daily 1

These agents are as effective as octreotide in reducing stomal output volume without changing macronutrient absorption. 1, 6

Step 5: Octreotide (Fourth-Line)

Octreotide 50 mcg subcutaneously twice daily is reserved for refractory cases, particularly those with net secretory output >3 L/24 hours. 6

  • Most effective in patients with secretory-type high output 1, 6
  • Can reduce output by 1-2 L/24 hours 6
  • Does not improve nutrient absorption and may not eliminate need for parenteral support 1, 6
  • Long-term effects on intestinal adaptation are uncertain 6

Step 6: Electrolyte Correction

Hypomagnesemia management (common with high output):

  • Initial IV magnesium sulfate, then oral magnesium oxide 4 mmol capsules (160 mg MgO), 12-24 mmol daily, preferably at night 1, 5
  • Rehydration to correct secondary hyperaldosteronism is the critical first step 1

Hypokalemia typically resolves with sodium/water repletion and magnesium correction; direct potassium supplementation rarely needed. 1

Step 7: Parenteral Support

For patients failing oral/pharmacologic management, provide:

  • Subcutaneous saline (0.5-1 L with 4 mmol magnesium sulfate) if needed 1-3 times weekly 1
  • IV saline via tunneled central line if more frequent administration required 1
  • Parenteral nutrition if undernutrition develops 1

Special Considerations for Jejunostomy

Jejunostomy outputs are typically higher (sodium content ~90 mmol/L) and require more aggressive fluid/electrolyte management. 1

Patients with <50 cm remaining jejunum often require long-term parenteral support. 1, 4

Critical Pitfalls to Avoid

  • Never encourage drinking large volumes of hypotonic fluids to quench thirst—this worsens sodium depletion 1, 5
  • Avoid excessive IV fluid administration during rehydration, which causes edema due to elevated aldosterone 1
  • Don't overlook hypomagnesemia, which perpetuates hypokalemia and is resistant to potassium replacement alone 1
  • Ensure medications are given 30 minutes before meals as output increases postprandially 1, 6
  • Crush tablets/capsules if they appear intact in stoma output 1

Outcomes and Prognosis

  • Early high-output ileostomy occurs in 16% of cases, with 49% resolving spontaneously and 51% requiring ongoing treatment 4
  • Readmission rates for ileostomy-related dehydration approach 31% in some series 7
  • Intestinal adaptation occurs over weeks to months, potentially reducing output requirements 2
  • Patients with jejunostomy or <200 cm small bowel have the highest risk for persistent high output requiring long-term support 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ileostomy diarrhea: Pathophysiology and management.

Proceedings (Baylor University. Medical Center), 2020

Research

Causes and management of a high-output stoma.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2011

Guideline

Treatment of Metabolic Acidosis Related to High Output Ileostomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Octreotide Therapy for Managing High Ileostomy Output

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.